Science
Mechanism of Action
This polypeptide functions by binding to specific Epidermal Growth Factor Receptors (EGFRs) found on the surface of various skin cells. This crucial interaction initiates a cascade of intracellular events that promote essential cellular functions, including proliferation, differentiation, and tissue repair. Its action specifically encourages the growth of epidermal cells, keratinocytes, endothelial cells, and fibroblasts, simultaneously boosting the production of vital extracellular matrix components like collagen, elastin, and hyaluronic acid.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 A systematic review indicated that 73% of subjects applying a topical EGF serum twice daily for 8 weeks observed a reduction in melasma without adverse effects.
- 02 An EGF cream demonstrated a 33.5% reduction in inflammatory acne lesions in a study of 20 subjects over six weeks.
- 03 Effective in promoting wound healing in diabetic patients following laser treatment and in the management of Senile purpura.
- 04 A 2012 study on a serum containing barley bioengineered EGF showed statistically significant improvements in fine lines, rhytids, skin texture, pore size, and various dyschromatic conditions within three months.
Transparency
Dusting Analysis
As a complex, biologically active peptide, SH-Oligopeptide-1 is recognized for its specific cellular signaling functions. Its inclusion in formulations is typically for its active benefits rather than as a cosmetic filler, making 'dusting' highly improbable.
The Formula
Formulation
Stability
Given its medium size and polar molecular structure, a specialized delivery system may be essential to facilitate effective skin penetration and maximize its therapeutic efficacy.
Safety
Safety Profile
Generally considered safe for cosmetic use due to its biocompatibility and biodegradability. However, some reviews suggest that clinical studies supporting its functional EGF claims in cosmetics may lack sufficient scientific rigor, classifying active EGF as a potent, unauthorized drug. While authorized in cosmetics at various concentrations, long-term risks remain undefined. As a growth factor, there is a theoretical potential for SH-Oligopeptide-1 to promote tumorigenesis if there is cellular overexpression or dysregulation, given the role of EGF signaling in numerous tumor cells. Therefore, caution is advised for products containing EGF-mimetic ingredients, particularly for individuals with existing skin cancer risk factors or psoriasis.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite exhibiting promising anti-aging, skin-restoring, and reparative benefits in clinical studies, the lack of precise concentration data, an unreviewed CIR status, unknown long-term risks, and theoretical tumorigenesis concerns warrant a highly cautious and discerning approach to its use.
Related
Similar Ingredients
Finding similar ingredients…